[HTML][HTML] Practice advisory update summary: patent foramen ovale and secondary stroke prevention: report of the Guideline Subcommittee of the American Academy of …

SR Messé, GS Gronseth, DM Kent, JR Kizer… - Neurology, 2020 - ncbi.nlm.nih.gov
Objective To update the 2016 American Academy of Neurology (AAN) practice advisory for
patients with stroke and patent foramen ovale (PFO). Methods The guideline panel followed …

Second consensus document on diagnosis and management of acute deep vein thrombosis: updated document elaborated by the ESC Working Group on aorta and …

L Mazzolai, W Ageno, A Alatri… - European journal of …, 2022 - academic.oup.com
This consensus document is proposed to clinicians to provide the whole spectrum of deep
vein thrombosis management as an update to the 2017 consensus document. New data …

[HTML][HTML] Assessment and mitigation of bleeding risk in atrial fibrillation and venous thromboembolism: executive summary of a European and Asia-Pacific expert …

DA Gorog, YX Gue, TF Chao, L Fauchier… - Thrombosis and …, 2022 - thieme-connect.com
While there is a clear clinical benefit of oral anticoagulation in patients with atrial fibrillation
(AF) and venous thromboembolism (VTE) in reducing the risks of thromboembolism, major …

Diagnosis and treatment of lower extremity venous thromboembolism: a review

R Chopard, IE Albertsen, G Piazza - Jama, 2020 - jamanetwork.com
Importance Incidence rates for lower extremity deep vein thrombosis (DVT) range from 88 to
112 per 100 000 person-years and increase with age. Rates of recurrent VTE range from …

[HTML][HTML] Platelets and their role in hemostasis and thrombosis—From physiology to pathophysiology and therapeutic implications

A Scridon - International Journal of Molecular Sciences, 2022 - mdpi.com
Hemostasis is a physiological process critical for survival. Meanwhile, thrombosis is
amongst the leading causes of death worldwide, making antithrombotic therapy one of the …

Venous thromboembolism

F Khan, T Tritschler, SR Kahn, MA Rodger - The lancet, 2021 - thelancet.com
Venous thromboembolism, comprising both deep vein thrombosis and pulmonary embolism,
is a chronic illness that affects nearly 10 million people every year worldwide. Strong …

[HTML][HTML] Platelet in thrombo-inflammation: Unraveling new therapeutic targets

S Sharma, T Tyagi, S Antoniak - Frontiers in immunology, 2022 - frontiersin.org
In the broad range of human diseases, thrombo-inflammation appears as a clinical
manifestation. Clinically, it is well characterized in context of superficial thrombophlebitis that …

[PDF][PDF] Deep vein thrombosis: update on diagnosis and management

PC Kruger, JW Eikelboom, JD Douketis… - Medical Journal of …, 2019 - mja.com.au
Deep vein thrombosis: update on diagnosis and management Page 1 Narrative review MJA 2 10
(11) ▪ 17 June 2 0 19 Deep vein thrombosis: update on diagnosis and management Paul C …

[PDF][PDF] Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study

MA Rodger, G Le Gal, DR Anderson, J Schmidt… - Bmj, 2017 - bmj.com
Objective To prospectively validate the HERDOO2 rule (Hyperpigmentation, Edema, or
Redness in either leg; D-dimer level≥ 250 μg/L; Obesity with body mass index≥ 30; or …

[HTML][HTML] The dual role of platelet‐innate immune cell interactions in thrombo‐inflammation

J Rayes, JH Bourne, A Brill, SP Watson - Research and practice in …, 2020 - Elsevier
Beyond their role in hemostasis and thrombosis, platelets are increasingly recognized as
key regulators of the inflammatory response under sterile and infectious conditions. Both …